FRANK OSTERKAMP

Person

BERLIN, DE

People

Patents Grantslast 30 patents

Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 11,793,855
- Issue date Oct 24, 2023
- Takeda Pharmaceutical Company Limited
- Michael Dockal
- G01 - MEASURING TESTING
Information Patent Grant
Neurotensin receptor ligands
- Patent number 10,961,199
- Issue date Mar 30, 2021
- 3B PHARMACEUTICALS GMBH
- Frank Osterkamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 10,800,816
- Issue date Oct 13, 2020
- Baxalta GmbH
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Conjugate comprising a neurotensin receptor ligand and use thereof
- Patent number 10,799,605
- Issue date Oct 13, 2020
- 3B PHARMACEUTICALS GMBH
- Frank Osterkamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 10,201,586
- Issue date Feb 12, 2019
- Baxalta GmbH
- Michael Dockal
- G01 - MEASURING TESTING
Information Patent Grant
NPR-B agonists
- Patent number 10,196,423
- Issue date Feb 5, 2019
- Shire Orphan Therapies GmbH
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptides and methods of use
- Patent number 10,124,033
- Issue date Nov 13, 2018
- Baxalta Incorporated
- Michael Dockal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NPR-B agonists
- Patent number 9,982,016
- Issue date May 29, 2018
- Shire Orphan Therapies GmbH
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 9,873,720
- Issue date Jan 23, 2018
- Baxalta GmbH
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NPR-B agonists
- Patent number 9,745,344
- Issue date Aug 29, 2017
- Shire Orphan Therapies GmbH
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 9,556,230
- Issue date Jan 31, 2017
- BAXALTA GMBH
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic peptide-based NPR-B agonists
- Patent number 9,458,198
- Issue date Oct 4, 2016
- Shire Orphan Therapies GmbH
- Frank Osterkamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and methods of use
- Patent number 9,447,147
- Issue date Sep 20, 2016
- Baxalta GmbH
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NPR-B agonists
- Patent number 9,169,293
- Issue date Oct 27, 2015
- Shire Orphan Thereapies GmbH
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 9,018,167
- Issue date Apr 28, 2015
- Baxter International Inc.
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 8,962,563
- Issue date Feb 24, 2015
- Baxter International, Inc.
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the inhibition of integrins and use thereof
- Patent number 8,927,534
- Issue date Jan 6, 2015
- Shire Orphan Therapies GmbH
- Gunther Zischinsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NPR-B agonists
- Patent number 8,546,523
- Issue date Oct 1, 2013
- Alcon Research, Ltd.
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the inhibition of angiogenesis and use thereof
- Patent number 8,501,787
- Issue date Aug 6, 2013
- Shire Orphan Therapies GmbH
- Grit Zahn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TFPI inhibitors and methods of use
- Patent number 8,450,275
- Issue date May 28, 2013
- Baxter International Inc.
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds for the inhibition of integrins and use thereof
- Patent number 8,309,735
- Issue date Nov 13, 2012
- Shire Orphan Therapies GmbH
- Gunther Zischinsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for determining the substrate specificity of an enzyme
- Patent number 8,029,979
- Issue date Oct 4, 2011
- JPT Peptide Technologies GmbH
- Jens Schneider-Mergener
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF
- Publication number 20240335569
- Publication date Oct 10, 2024
- 3 B PHARMACEUTICALS GMBH
- Frank OSTERKAMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...
- Publication number 20240115745
- Publication date Apr 11, 2024
- 3B Pharmaceuticals GmbH
- Frank OSTERKAMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...
- Publication number 20230212549
- Publication date Jul 6, 2023
- 3B Pharmaceuticals GmbH
- Frank OSTERKAMP
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...
- Publication number 20220315554
- Publication date Oct 6, 2022
- 3B Pharmaceuticals GmbH
- Frank OSTERKAMP
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...
- Publication number 20220273831
- Publication date Sep 1, 2022
- 3B Pharmaceuticals GmbH
- Frank OSTERKAMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROTENSIN RECEPTOR LIGANDS
- Publication number 20210087149
- Publication date Mar 25, 2021
- 3B Pharmaceuticals
- Frank OSTERKAMP
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20190134147
- Publication date May 9, 2019
- Baxalta GmbH
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NPR-B Agonists
- Publication number 20180334477
- Publication date Nov 22, 2018
- SHIRE ORPHAN THERAPIES GMBH
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20180155399
- Publication date Jun 7, 2018
- Baxalta GmbH
- MICHAEL DOCKAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NPR-B Agonists
- Publication number 20170313743
- Publication date Nov 2, 2017
- SHIRE ORPHAN THERAPIES GMBH
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20170174727
- Publication date Jun 22, 2017
- Baxalta GmbH
- MICHAEL DOCKAL
- G01 - MEASURING TESTING
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20170157198
- Publication date Jun 8, 2017
- Baxalta GmbH
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF
- Publication number 20170119913
- Publication date May 4, 2017
- Frank Osterkamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES AND METHODS OF USE
- Publication number 20170035835
- Publication date Feb 9, 2017
- BAXALTA INCORPORATED
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROTENSIN RECEPTOR LIGANDS
- Publication number 20150299133
- Publication date Oct 22, 2015
- 3 B Pharmaceuticals GmbH
- Frank OSTERKAMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES AND METHODS OF USE
- Publication number 20150246947
- Publication date Sep 3, 2015
- Baxter International Inc.
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20150232514
- Publication date Aug 20, 2015
- Baxter International Inc.
- Michael Dockal
- G01 - MEASURING TESTING
Information Patent Application
NOVEL NPR-B AGONISTS
- Publication number 20130345394
- Publication date Dec 26, 2013
- ALCON RESEARCH, LTD.
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20130259863
- Publication date Oct 3, 2013
- Michael Dockal
- G01 - MEASURING TESTING
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20130252896
- Publication date Sep 26, 2013
- BAXTER HEALTHCARE SA
- Michael Dockal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TFPI INHIBITORS AND METHODS OF USE
- Publication number 20120028901
- Publication date Feb 2, 2012
- Baxter International Inc.
- MICHAEL DOCKAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL NPR-B AGONISTS
- Publication number 20110077381
- Publication date Mar 31, 2011
- ALCON RESEARCH, LTD.
- Frank Osterkamp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF
- Publication number 20110065760
- Publication date Mar 17, 2011
- Jerini AG
- Jochen Knolle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF
- Publication number 20090203745
- Publication date Aug 13, 2009
- Jerini AG
- Gunther Zischinsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF
- Publication number 20090104116
- Publication date Apr 23, 2009
- Jerini AG
- Gunter Zischinsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the inhibition of angiogenesis and use thereof
- Publication number 20070155712
- Publication date Jul 5, 2007
- Jerini AG
- Grit Zahn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenol derivatives and their use as rotamase inhibitors
- Publication number 20070054904
- Publication date Mar 8, 2007
- Jerini AG
- Jochen Knolle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for determining the substrate specificity of an enzymatic ac...
- Publication number 20060234308
- Publication date Oct 19, 2006
- Jerini AG
- Jens Schneider-Mergener
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for determining the substrate specificity of an enzymatic ac...
- Publication number 20040171097
- Publication date Sep 2, 2004
- Jens Schneider-Mergener
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

FRANK OSTERKAMP

Person

Patents Grantslast 30 patents

TFPI inhibitors and methods of use

Neurotensin receptor ligands

TFPI inhibitors and methods of use

Conjugate comprising a neurotensin receptor ligand and use thereof

TFPI inhibitors and methods of use

NPR-B agonists

Peptides and methods of use

NPR-B agonists

TFPI inhibitors and methods of use

NPR-B agonists

TFPI inhibitors and methods of use

Cyclic peptide-based NPR-B agonists

Peptides and methods of use

NPR-B agonists

TFPI inhibitors and methods of use

TFPI inhibitors and methods of use

Compounds for the inhibition of integrins and use thereof

NPR-B agonists

Compounds for the inhibition of angiogenesis and use thereof

TFPI inhibitors and methods of use

Heterocyclic compounds for the inhibition of integrins and use thereof

Method for determining the substrate specificity of an enzyme

Patents Applicationslast 30 patents

FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE...

NEUROTENSIN RECEPTOR LIGANDS

TFPI INHIBITORS AND METHODS OF USE

NPR-B Agonists

TFPI INHIBITORS AND METHODS OF USE

NPR-B Agonists

TFPI INHIBITORS AND METHODS OF USE

TFPI INHIBITORS AND METHODS OF USE

CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF

PEPTIDES AND METHODS OF USE

NEUROTENSIN RECEPTOR LIGANDS

PEPTIDES AND METHODS OF USE

TFPI INHIBITORS AND METHODS OF USE

NOVEL NPR-B AGONISTS

TFPI INHIBITORS AND METHODS OF USE

TFPI INHIBITORS AND METHODS OF USE

TFPI INHIBITORS AND METHODS OF USE

NOVEL NPR-B AGONISTS

COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF

COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF

Compounds for the inhibition of angiogenesis and use thereof

Phenol derivatives and their use as rotamase inhibitors

Method for determining the substrate specificity of an enzymatic ac...

Method for determining the substrate specificity of an enzymatic ac...